Does INFLIXIMAB Cause Pulmonary fibrosis? 1,595 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,595 reports of Pulmonary fibrosis have been filed in association with INFLIXIMAB (Renflexis). This represents 1.1% of all adverse event reports for INFLIXIMAB.
1,595
Reports of Pulmonary fibrosis with INFLIXIMAB
1.1%
of all INFLIXIMAB reports
592
Deaths
962
Hospitalizations
How Dangerous Is Pulmonary fibrosis From INFLIXIMAB?
Of the 1,595 reports, 592 (37.1%) resulted in death, 962 (60.3%) required hospitalization, and 712 (44.6%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
Yes, Pulmonary fibrosis is listed as a known adverse reaction in the official FDA drug label for INFLIXIMAB.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
SULFASALAZINE (1,428)
Which INFLIXIMAB Alternatives Have Lower Pulmonary fibrosis Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT